Laura Kupsch
Vice President Quality Assurance
Professional Overview
Laura Kupsch is an experienced quality assurance executive with a proven track record of driving excellence in the pharmaceutical and biotechnology industries. With her multifaceted expertise spanning quality assurance, compliance, and regulatory affairs, she is renowned for her ability to implement robust quality systems and processes that ensure product safety and efficacy.
Experience Summary
Current Roles
As the Vice President of Quality Assurance at EyeBio, Passage Bio, Melinta Therapeutics, Nutrinia, and Ophthotech Corp., Laura oversees the development, implementation, and maintenance of comprehensive quality management systems. She is responsible for leading cross-functional teams to achieve compliance with cGMP, cGLP, and cGCP regulations, while fostering a culture of continuous improvement and quality-focused decision-making.
Career Progression
Throughout her distinguished career, Laura has held progressively senior roles, demonstrating her ability to drive strategic initiatives and deliver measurable results. Prior to her current positions, she served as the Executive Director, Head of Quality at Nutrinia and the Sr. Director of Quality Assurance at Ophthotech Corp. These roles have allowed her to hone her expertise in quality systems, process optimization, and regulatory compliance.
Academic Background
Laura holds a Bachelor's degree in Pharmaceutical Sciences from the University of Wisconsin-Madison, where she graduated with Honors. Her academic achievements and specialized knowledge in the field have been instrumental in her success as a quality assurance leader.
Areas of Expertise
- Quality assurance and quality control systems
- cGMP, cGLP, and cGCP compliance
- Regulatory affairs and submissions
- Process optimization and continuous improvement
- Cross-functional team leadership and collaboration
- Risk management and mitigation strategies
Professional Impact
Throughout her career, Laura has demonstrated her ability to drive significant improvements in quality and compliance across the organizations she has served. Her leadership has been instrumental in the successful launch of several pharmaceutical and biotechnology products, ensuring patient safety and product efficacy.
Conclusion
With her extensive experience, technical expertise, and proven track record of excellence, Laura Kupsch is a highly respected quality assurance executive. Her dedication to continuous improvement and her ability to foster a culture of quality make her a valuable asset to any organization in the pharmaceutical and biotechnology industries.
